Age group
|
10–20
|
Count
|
0
|
0
|
13
|
2
|
0
|
8
|
23
|
% prevalence within Age group
|
.0%
|
.0%
|
56.5%
|
8.7%
|
.0%
|
34.8%
|
100.0%
|
% prevalence within Genotype
|
.0%
|
.0%
|
6.5%
|
8.0%
|
.0%
|
17.8%
|
7.3%
|
20–30
|
Count
|
4
|
1
|
53
|
5
|
7
|
11
|
81
|
% prevalence within Age group
|
4.9%
|
1.2%
|
65.4%
|
6.2%
|
8.6%
|
13.6%
|
100.0%
|
% prevalence within Genotype
|
26.7%
|
11.1%
|
26.5%
|
20.0%
|
31.8%
|
24.4%
|
25.6%
|
30–40
|
Count
|
7
|
3
|
62
|
8
|
5
|
12
|
97
|
% prevalence within Age group
|
7.2%
|
3.1%
|
63.9%
|
8.2%
|
5.2%
|
12.4%
|
100.0%
|
% prevalence within Genotype
|
46.7%
|
33.3%
|
31.0%
|
32.0%
|
22.7%
|
26.7%
|
30.7%
|
40–50
|
Count
|
4
|
4
|
40
|
5
|
6
|
6
|
65
|
% prevalence within Age group
|
6.2%
|
6.2%
|
61.5%
|
7.7%
|
9.2%
|
9.2%
|
100.0%
|
% prevalence within Genotype
|
26.7%
|
44.4%
|
20.0%
|
20.0%
|
27.3%
|
13.3%
|
20.6%
|
50–60
|
Count
|
0
|
1
|
27
|
5
|
4
|
8
|
45
|
% prevalence within Age group
|
.0%
|
2.2%
|
60.0%
|
11.1%
|
8.9%
|
17.8%
|
100.0%
|
% prevalence within Genotype
|
.0%
|
11.1%
|
13.5%
|
20.0%
|
18.2%
|
17.8%
|
14.2%
|
60+
|
Count
|
0
|
0
|
5
|
0
|
0
|
0
|
5
|
% prevalence within Age group
|
.0%
|
.0%
|
100.0%
|
.0%
|
.0%
|
.0%
|
100.0%
|
% prevalence within Genotype
|
.0%
|
.0%
|
2.5%
|
.0%
|
.0%
|
.0%
|
1.6%
|
Total
|
Count
|
15
|
9
|
200
|
25
|
22
|
45
|
316
|
% prevalence within Age group
|
4.7%
|
2.8%
|
63.3%
|
7.9%
|
7.0%
|
14.2%
|
100.0%
|
% prevalence within Genotype
|
100.0%
|
100.0%
|
100.0%
|
100.0%
|
100.0%
|
100.0%
|
100.0%
|